Panacea Biotec informs about press release

18 Jan 2018 Evaluate

Panacea Biotec has informed about the collaboration with signing of two long term agreements with Serum Institute of India (SII) and SIIs wholly owned subsidiary, Bilthovan Biologicals B.V. (BBIO). A copy of the Press Release is being submitted.

The above information is a part of company’s filings submitted to BSE.

Panacea Biotec Share Price

146.05 4.05 (2.85%)
25-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1520.55
Dr. Reddys Lab 6217.15
Cipla 1405.40
Zydus Lifesciences 953.50
Lupin 1589.10
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.